XML 71 R66.htm IDEA: XBRL DOCUMENT v2.4.0.8
14. SEGMENTS (Details) (USD $)
 12 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Mar. 31, 2012
Total Revenues $ 1,623,769 $ 1,230,004  
Total Operating Loss (3,055,928) (3,575,354)  
Net Loss (13,357,232) (4,892,040)  
Total Assets 1,695,102 496,694  
Total Cash 1,250,279 125,274 143,907
Capital Expenditures (96,056) 0  
Total Depreciation and Amortization 21,087 10,484  
Total Interest Expense (1,287,221) (1,132,314)  
Aethlon Medical, Inc
      
Total Revenues 1,623,769 1,230,004  
Total Operating Loss (2,651,863) (3,575,354)  
Net Loss (13,357,232) (4,892,040)  
Total Assets 597,026 496,694  
Total Cash 208,259 125,274  
Capital Expenditures 37,313 0  
Total Depreciation and Amortization 11,549 10,484  
Total Interest Expense 1,282,638 1,132,314  
Exosome Sciences, Inc
      
Total Revenues 0 0  
Total Operating Loss (404,065) 0  
Net Loss (81,730) 0  
Total Assets 1,098,076 0  
Total Cash 1,042,020 0  
Capital Expenditures 58,743 0  
Total Depreciation and Amortization 9,538 0  
Total Interest Expense $ 4,583 $ 0